MedTrace Logo

Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population

NCT05983042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-08-09

No results posted yet for this study

Summary

The goal of this Observational study was to identify the effect of CYP2C9 gene polymorphism in the Pakistani population. The main question it aims to answer were:

* to evaluate the effect of this genetic polymorphism on the clinical efficacy of Ibuprofen
* to evaluate the effect of this genetic polymorphism on the clinical tolerability of Ibuprofen Participants were prescribed Ibuprofen after molar tooth extraction.

Conditions

  • Healthy Volunteers

Interventions

GENETIC

Ibuprofen

Ibuprofen 400mg three times a day for three days

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Ammarah Amjad, BDS · Riphah International University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05983042 on ClinicalTrials.gov